Concepedia

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely, Kathleen M. Mullane, John R. Perfect, George R. Thompson, George Alangaden, Janice M. Brown, David N. Fredricks, Werner Heinz,

The Lancet Infectious Diseases · 2016 · 694 citations · 24 references

DOI

Concepts

References

24

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text

, , +7

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

, , +10

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

Dimitrios P. Kontoyiannis, Kieren A. Marr, Benjamin J. Park et al. · Clinical Infectious Diseases · 2010 · 1.4K citations · Full text

, , +14

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 972 citations

, , +17

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 921 citations · Full text

, , +17